pubrio
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. logo

SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.

Public
3healthcare.com
研究產業2,200+ employeesFounded 2007🇨🇳 中國

Haohai Biological Technology (06826.HK) is a leading company in China focusing on R&D, manufacturing and sales of biomedical materials. We strategically target the fast-growing therapeutic areas in the biomedical materials market including ophthalmology, medical aesthetics and would healing, orthopedics, and anti-adhesion and hemostasis. We currently manufacture intraocular lens (IOL), medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF, etc. Based on the sales volume of the Company's IOL and the number of national cataract surgery cases, the Company has captured about 30% of the IOL market in the PRC. Meanwhile, the market share of Company's anti-adhesion products, OVD products and orthopedics viscosupplementation products was 49.05%, 45.93%, and 36.21%, respectively.

成立年份
2007
員工
2,200+
行業
研究產業
公司類型
Public Company
股票
shh: 688366.SS
總部
🇨🇳4f, No 2 Building, Alley 139, Shanghai, China (+1)
專長
研究產業

擴張情報

全新 · Pubrio 獨家

我們正在追蹤 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. 的市場擴張

全球擴張

即時
階段
探索中投入中進入中營運中
值得了解

關於 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. 的常見問題

關於 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. 業務、市場及增長訊號的快速解答。

Haohai Biological Technology (06826.HK) is a leading company in China focusing on R&D, manufacturing and sales of biomedical materials. We strategically target the fast-growing therapeutic areas in the biomedical materials market including ophthalmology, medical aesthetics and would healing, orthopedics, and anti-adhesion and hemostasis. We currently manufacture intraocular lens (IOL), medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF, etc. Based on the sales volume of the Company's IOL and the number of national cataract surgery cases, the Company has captured about 30% of the IOL market in the PRC. Meanwhile, the market share of Company's anti-adhesion products, OVD products and orthopedics viscosupplementation products was 49.05%, 45.93%, and 36.21%, respectively.

立即展開你的旅程

可以先用平台,也可以先聊聊

自行使用 Pubrio,或讓我們的團隊協助研究、挖掘潛在客戶,甚至串接資料。

Start Journey Image
pubrio

Pubrio 將 50+ 個在地來源的商業、人才與意圖數據全球化整合,讓 AI 與營收團隊掌握完整市場視野。

© 2026 Pubrio。版權所有。